Skip to main content

Peer Review reports

From: Benefit-risk assessment of traditional Chinese medicine preparations of sinomenine using multicriteria decision analysis (MCDA) for patients with rheumatoid arthritis

Original Submission
18 Aug 2022 Submitted Original manuscript
22 Nov 2022 Reviewed Reviewer Report - Lawrence D. Phillips
25 Dec 2022 Reviewed Reviewer Report - Shun-ku Lin
14 Jan 2023 Author responded Author comments - Zhitao Feng
17 Jan 2023 Author responded Author comments - Zhitao Feng
Resubmission - Version 2
14 Jan 2023 Submitted Manuscript version 2
25 Jan 2023 Reviewed Reviewer Report - Lawrence D. Phillips
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
27 Jan 2023 Editorially accepted
6 Feb 2023 Article published 10.1186/s12906-023-03864-6

You can find further information about peer review here.

Back to article page